Dr. Kim-Hien Dao is leading a study at OHSU for women aged 65 and older called WEAR, or Women Engaged in Advancing Research, to collect health and genetic data that may one day enable them to identify and prevent these often-fatal diseases.
(OHSU/Amanda Gibbs)

Study participant Judith Baggs is interviewed at the OHSU Gabriel Park Clinic, October 29, 2016. Baggs is part of an OHSU study for women aged 65 and older called WEAR, or Women Engaged in Advancing Research, to collect health and genetic data that may one day enable them to identify and prevent these often-fatal diseases.
(OHSU/Amanda Gibbs)

Study participants attend a blood draw at OHSU Gabriel Park Clinic, October 29, 2016 as part of an OHSU study for women aged 65 and older called WEAR, or Women Engaged in Advancing Research, to collect health and genetic data that may one day enable them to identify and prevent these often-fatal diseases.
(OHSU/Amanda Gibbs)

Postdoctoral researcher Cristina Espinosa runs an experiment, November 16, 2016. The early evidence found in research at OHSU by Espinosa, Dr. Sudarshan Anand and his team is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)

Postdoctoral researcher Cristina Espinosa runs an experiment, November 16, 2016. The early evidence found in research at OHSU by Espinosa, Dr. Sudarshan Anand and his team is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)

The early evidence from research by Dr. Sudarshan Anand and his team at OHSU is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)

Postdoctoral researcher Cristina Espinosa runs an experiment, November 16, 2016. The early evidence found in research at OHSU by Espinosa, Dr. Sudarshan Anand and his team is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)

Dr. Sudarshan Anand (left) and postdoctoral researcher Cristina Espinosa in their lab, November 16, 2016. The early evidence from research by Dr. Sudarshan Anand and his team at OHSU is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)

Postdoctoral researcher Cristina Espinosa runs an experiment, November 16, 2016. The early evidence found in research at OHSU by Espinosa, Dr. Sudarshan Anand and his team is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)